September 8, 2016
Cambridge, MA

Solid Observes World Duchenne Awareness Day

On Wednesday, September 7, 2016, Solid Biosciences joined the Jett Foundation and other members of the local Cambridge, MA community to observe World Duchenne Awareness Day.

The event convened many of those impacted by the disease - patients, families, industry, researchers, healthcare providers and local policy representatives - to show unity in finding a cure for Duchenne muscular dystrophy and demonstrate that innovation takes unfailing drive and commitment. It also celebrated Cambridge as a center of innovation in Duchenne muscular dystrophy.

Solid Biosciences joined the Jett Foundation and other members of the local Cambridge, MA community to observe World Duchenne Awareness Day 2016.

With the great city of Boston as a backdrop, the group came together and raised red lanterns along the Charles River, honoring those with Duchenne muscular dystrophy and celebrating hope for the future.

Follow the event on Twitter #WDAD16 and #DuchenneCambridge.

Related news

Jan30

The Duchenne Research Fund (DRF) provided Solid with a research grant of $600,000 to support its LTBP4 program to combat fibrosis and to support novel biomarker work in Duchenne muscular dystrophy (DMD).

Oct14

It has been an exciting and emotional time for our Duchenne muscular dystrophy (DMD) community.

Sep20

Solid Biosciences congratulates Sarepta on the U.S. approval of the first therapy for Duchenne muscular dystrophy.

Sep15

Solid was proud to sponsor the 8th Annual Gals For Cal team at the recent Max Performance Title 9 Triathlon at Hopkinton State Park in Massachusetts.

Jun17

Solid Biosciences Community Update Q2 2016

Jun13

Grants from the charities Duchenne Now, Save Our Sons and Fight DMD will support important work in furthering Solid’s gene therapy and disease modifying therapy programs.

Jun09

The biologic candidate LTBP4 has the potential to promote muscle health and reduce fibrosis in patients with Duchenne muscular dystrophy.

May28

Carl Morris, Solid Biosciences’ vice president of Research and Development, speaks about being a “Game Changer in Rare Disease.”

Pages

More information about Solid?

Please subscribe to receive our latest news